|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Sales, net of returns and allowances | |||||
| Cost of sales | |||||
| Gross loss | |||||
| Operating expenses: | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Impairment loss on discontinued product line investment | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest expense, net | |||||
| Fair value gain (loss) on warrants | |||||
| Change in fair value of stock rights | |||||
| Other (loss) income | |||||
| Loss before income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Net loss per share of common stock - basic (in dollars per share) | |||||
| Net loss per share of common stock - diluted (in dollars per share) | |||||
| Weighted average shares used in computing net loss per share of common stock - basic (in shares) | |||||
| Weighted average shares used in computing net loss per share of common stock - diluted (in shares) |
Loading...
